Popular
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Peter Rossing, MD, DMSc
When Skin and Itch Do Not Match in Atopic Dermatitis
Dermatology Hub: Neuroimmune NetworkWhen Skin and Itch Do Not Match in Atopic Dermatitis
Elizabeth Swanson, MD, FAAD
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Treatment Challenges with Chronic Atopic Dermatitis
Practical DermatologyTreatment Challenges with Chronic Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Programs
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Ambulatory Monitoring Approaches for PSVT: Which One and When?
MinuteCE®Ambulatory Monitoring Approaches for PSVT: Which One and When?
Jennifer Carlquist, PA-C
Brian P. Rose, PA-C, MPH
Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
Dakota Price, MD
Emma Atkinson, PharmD
Bridging Obesity and MASLD Through Metabolic Dysfunction
Virtual EventBridging Obesity and MASLD Through Metabolic Dysfunction
October 22, 2026
06:00 PM - 07:00 PM ET
Why Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Practical DermatologyWhy Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Clinical Practice
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Komal Jhaveri, MD, FACP
ACACIA-HCM: What Do the Phase 3 Results Show?
CardiologyACACIA-HCM: What Do the Phase 3 Results Show?
Ahmad Masri, MD, MS
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Doctors Lounge
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Jean-Claude Saghbini
Earlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
The ConvergenceEarlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
Brian P. McDonough, MD, FAAFP
Adrian Noriega de la Colina, MD, PhD
Arvid E. Gollwitzer
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Bruno Batinica, MD
AI in Point-of-Care Ultrasound: Balancing Innovation With Clinical Judgment
Clinician's RoundtableAI in Point-of-Care Ultrasound: Balancing Innovation With Clinical Judgment
Taro Minami, MD, FCCP
CME
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
LGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
CME/CELGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
Kaitlin Batley, MD
Peter Karachunski, MD
- CME/CE In-Person & Virtual Event
Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
MinuteCE®Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Virginia Kaklamani, MD, DSc
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
MinuteCE®Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
Saad Z. Usmani, MD, MBA
Industry Feature
Treatment Considerations in Ulcerative Colitis: Shared Decision-Making
Medical Industry FeatureTreatment Considerations in Ulcerative Colitis: Shared Decision-Making
David T. Rubin, MD
Josh Steinberg, MD
Bowel Urgency as a Key Symptom in Ulcerative Colitis
Medical Industry FeatureBowel Urgency as a Key Symptom in Ulcerative Colitis
Ehsan Navabi, MD
Christie Morrison, NP
Single-Port Robotics Improves Outcomes for Thoracic Surgery
Medical Industry FeatureSingle-Port Robotics Improves Outcomes for Thoracic Surgery
Benjamin Lee, M.D.
Jeffrey Port, M.D.
Jonathan Villena-Vargas, M.D.
A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Shiv Bhadola, MD
Unraveling PMR Pathophysiology: The Central Role of IL-6
Medical Industry FeatureUnraveling PMR Pathophysiology: The Central Role of IL-6
Charles Turck, PharmD, BCPS, BCCCP
Adam Brown, MD
Megan Sullivan, MD
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Jennifer Caudle, DO, FACOFP
Syma Iqbal, MD